Overview: US Tax Policy and Indian Pharma The Trump administration’s second term has been marked by a push toward protectionist tax measures, tariffs, and tighter control on foreign-based operations. In this context, India’s booming pharmaceutical industry—an ecosystem where the United States represents a major, sometimes dominant market—faces questions about how new fiscal rules might reshape…